Skip to main content

Does Nuplazid treat Parkinson's disease?

Medically reviewed by Leigh Ann Anderson, PharmD. Last updated on March 11, 2024.

Official answer

by Drugs.com

Nuplazid (generic name: pimavanserin) was approved for the treatment of psychosis (hallucinations and delusions) associated with Parkinson’s disease. Nuplazid does not treat the typical motor symptoms of Parkinson's disease, such as tremors or shuffling gait.

Hallucinations or delusions can occur in up to one-half of patients with Parkinson’s disease. In clinical studies of 199 participants, Nuplazid was shown to be superior to placebo in decreasing the frequency and/or severity of hallucinations and delusions without worsening the primary motor symptoms of Parkinson’s disease.

What drug class is Nuplazid?

Nuplazid is a non-dopaminergic, selective serotonin inverse agonist (SSIA) atypical antipsychotic with no measurable activity at dopaminergic receptors, unlike many other antipsychotics.

  • However, as with other antipsychotics, Nuplazid is NOT approved for the treatment of patients with dementia-related psychosis unrelated to the hallucinations and delusions associated with Parkinson’s disease psychosis due to an increased risk of death.
  • Nuplazid carries a Boxed Warning for this risk, as does other antipsychotics.

Common side effects (occurring in at least 5% of patients) with Nuplazid include: swelling (peripheral edema) and confusion. Other side effects are: nausea, constipation, gait disturbance and hallucinations.

Nuplazid can also lead to QT interval prolongation, which is a serious rhythm disorder of the heart.

Related: Nuplazid side effects (in more detail)

This is not all the information you need to know about Nuplazid (pimavanserin) for safe and effective use and does not take the place of talking to your doctor about your treatment. Review the full Nuplazid information here, and discuss this information and any questions you have with your doctor or other health care provider.

Related questions

References

Read next

How does levodopa help Parkinson's disease?

Levodopa is a central nervous system agent that helps people with Parkinson’s because it is converted into dopamine in the brain. It helps to alleviate the symptoms of the disease by providing a supply of dopamine, which is lacking in people with Parkinson's.

Levodopa works best to help treat the slowness and stiffness or rigidity associated with Parkinson’s disease, and in some cases may treat the tremor as well. It does not slow or reduce the progression of Parkinson’s disease. Continue reading

How much does Inbrija cost?

The out-of-pocket cash price for Inbrija (levodopa inhalation) 42 mg inhalation capsules is about $1,295 for a supply of 60 capsules, but most people do not pay this price. If you have commercial insurance and Inbrija is covered on your plan, you may be eligible to receive it for as little as $30 per month. Continue reading

What is Creatine used for?

Creatine is an amino acid that is naturally found in the body - mostly in muscles - where it is stored as creatine phosphate (phosphocreatine). During high-intensity, short-duration sports, phosphocreatine is converted into ATP - the major form of energy used by the body. Our liver, kidneys, and pancreas synthesize about 50% of the creatine in our body - which is then transported to our muscles via our blood. The other 50% is obtained through our diet with meat and fish notably high in creatine.

Continue reading

Related medical questions

Drug information

Related support groups